Unassociated Document
May 7,
2010
Securities
and Exchange Commission
100 F
Street, NE
Washington,
D.C. 20549
|
|
Re:
|
Medasorb
Technologies Corporation
|
|
|
|
|
Registration
Statement on Form S-1
Filed
with the Securities and Exchange Commission on June 22, 2009
(Registration
No. 333-156081)
Request
for Withdrawal
Ladies
and Gentlemen:
Pursuant
to Rule 477 promulgated under the Securities Act of 1933, Medasorb Technologies
Corporation (the “Company”), hereby applies for the withdrawal of its
registration statement on Form S-1, File No. 333-156081, which was filed on June
22, 2009 (the “Registration Statement”).
Such
withdrawal is requested because the shares being registered on the Form S-1 can
now be sold by most of the selling shareholders under Rule
144. As a result, the Company determined that it should withdraw the
Registration Statement.
No sales
of any of the Company's securities have been completed and the Registration
Statement has not been declared effective by the Commission. However, the
Company may undertake a private offering in the future in reliance on Securities
Act Rule 155(c).
Should
you have any comments please contact the Company’s legal counsel, Gregg E.
Jaclin, Esq. at (732) 409-1212.
|
|
Very
truly yours,
|
|
|
|
|
|
MEDASORB
TECHNOLOGIES CORPORATION
|
|
|
|
|
|
|
By:
|
/s/ Dr. Phillip
Chan
|
|
|
Dr.
Phillip Chan
|
|
|
Chief
Executive Officer
and
President
|